Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Other financing activities: 2019-2023

Historic Other financing activities for Beam Therapeutics (BEAM) over the last 5 years, with Dec 2023 value amounting to $631,000.

  • Beam Therapeutics' Other financing activities rose 1436.00% to $384,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $685,000, marking a year-over-year increase of 161.45%. This contributed to the annual value of $631,000 for FY2023, which is 235.64% up from last year.
  • Beam Therapeutics' Other financing activities amounted to $631,000 in FY2023, which was up 235.64% from $188,000 recorded in FY2022.
  • Beam Therapeutics' Other financing activities' 5-year high stood at $8.8 million during FY2021, with a 5-year trough of $188,000 in FY2022.
  • For the 3-year period, Beam Therapeutics' Other financing activities averaged around $3.2 million, with its median value being $631,000 (2023).
  • As far as peak fluctuations go, Beam Therapeutics' Other financing activities surged by 328.17% in 2021, and later plummeted by 97.87% in 2022.
  • Over the past 5 years, Beam Therapeutics' Other financing activities (Yearly) stood at $2.5 million in 2019, then declined by 18.33% to $2.1 million in 2020, then spiked by 328.17% to $8.8 million in 2021, then plummeted by 97.87% to $188,000 in 2022, then soared by 235.64% to $631,000 in 2023.